These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33038745)

  • 21. Patisiran for the treatment of hereditary transthyretin-mediated amyloidosis.
    Yang J
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):95-99. PubMed ID: 30644768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
    Coelho T; Maurer MS; Suhr OB
    Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transthyretin-related amyloidotic cardiomyopathy: looking for the etiological treatment].
    Longhi S; Gagliardi C; Milandri A; Manuzzi L; Rapezzi C
    G Ital Cardiol (Rome); 2014 May; 15(5):293-300. PubMed ID: 25002169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A genealogical and clinical study of the phenotypical variation within the Swedish transthyretin His88Arg (p. His108Arg) amyloidosis family.
    Hellman U; Lundgren HE; Westermark P; Stafberg C; Nahi H; Tachlinski S; Guggi M; Flogegård M; Hamid M; Escher SA; Suhr OB
    Eur J Med Genet; 2015 Apr; 58(4):211-5. PubMed ID: 25721874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of transthyretin-related cerebral amyloid angiopathy. The other side of hereditary transthyretin amyloidosis.
    Lemarchant B; Lebouvier T; Delbeuck X; Gibier JB; Tard C
    Acta Neurol Belg; 2022 Apr; 122(2):571-573. PubMed ID: 35040071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac Involvement in a Patient Cohort With Val30Met Mutation Transthyretin Amyloidosis.
    Ripoll-Vera T; Buades J; Cisneros E; Gómez Y; Núñez J; Raya M
    Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):92-94. PubMed ID: 29223374
    [No Abstract]   [Full Text] [Related]  

  • 27. A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G > T, p.Ala140Ser).
    Patel K; Tagoe C; Bieri P; Weidenheim K; Tauras JM
    Amyloid; 2018 Sep; 25(3):211-212. PubMed ID: 30039724
    [No Abstract]   [Full Text] [Related]  

  • 28. Establishment of an induced pluripotent stem cell line from a patient with primary ciliary dyskinesia carrying biallelic mutations in CCNO.
    Xu X; Dong L; Ma C; Xu X; Wu H; Wang J; Zhou P; Cao Y; Wei Z
    Stem Cell Res; 2021 May; 53():102372. PubMed ID: 34088001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
    Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells.
    Nakamura Y; Yutani C; Nakazato M; Date Y; Baba T; Goto Y
    Pathol Int; 1999 Oct; 49(10):898-902. PubMed ID: 10571824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new transthyretin mutation associated with amyloid cardiomyopathy.
    Saraiva MJ; Almeida Mdo R; Sherman W; Gawinowicz M; Costa P; Costa PP; Goodman DS
    Am J Hum Genet; 1992 May; 50(5):1027-30. PubMed ID: 1570831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of transthyretin cardiomyopathy with a TTR-specific antisense oligonucleotide (IONIS-TTR
    Benson MD; Ackermann EJ; Monia BP
    Amyloid; 2017 Mar; 24(sup1):134-135. PubMed ID: 28434337
    [No Abstract]   [Full Text] [Related]  

  • 33. Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis.
    Hendren NS; Roth LR; Grodin JL
    Curr Heart Fail Rep; 2020 Jun; 17(3):77-83. PubMed ID: 32356182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg.
    Watanabe T; Obayashi K; Misumi Y; Tasaki M; Shinriki S; Ando T; Akagami T; Ueda M; Yamashita T; Hirotani S; Ando Y
    Amyloid; 2017 Mar; 24(sup1):119. PubMed ID: 28434332
    [No Abstract]   [Full Text] [Related]  

  • 35. Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3.
    Dementyeva EV; Pavlova SV; Chernyavsky AM; Zakian SM
    Stem Cell Res; 2021 May; 53():102344. PubMed ID: 33892289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
    Paton DM
    Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel transthyretin variant p.H110D (H90D) as a cause of familial amyloid polyneuropathy in a large Irish kindred.
    Jimenez-Zepeda VH; Bahlis NJ; Gilbertson J; Rendell N; Porcari R; Lachmann HJ; Gillmore JD; Hawkins PN; Rowczenio DM
    Amyloid; 2015 Mar; 22(1):26-30. PubMed ID: 25430583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transthyretin amyloid cardiomyopathy.
    Garcia-Pavia P; Domínguez F; Gonzalez-Lopez E
    Med Clin (Barc); 2021 Feb; 156(3):126-134. PubMed ID: 33138983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
    Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
    J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.
    Adams D; Koike H; Slama M; Coelho T
    Nat Rev Neurol; 2019 Jul; 15(7):387-404. PubMed ID: 31209302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.